Skip to main content
. 2018 Oct 4;16:274. doi: 10.1186/s12967-018-1637-x

Fig. 6.

Fig. 6

Prognostic evaluation of the 4-mRNA signature in prostate cancer patients. a The distribution of mRNA-related survival risk scores and heatmap of the 4 prognostic mRNAs. b Kaplan–Meier analysis of overall survival in prostate cancer patients with the 4-mRNA signature. c ROC curve analysis of the 4-mRNA signature